ID   HCAR2_RAT               Reviewed;         360 AA.
AC   Q80Z39;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   24-JUL-2024, entry version 127.
DE   RecName: Full=Hydroxycarboxylic acid receptor 2;
DE   AltName: Full=G-protein coupled receptor 109;
DE   AltName: Full=G-protein coupled receptor 109A;
DE   AltName: Full=G-protein coupled receptor HM74;
DE   AltName: Full=Niacin receptor 1;
DE   AltName: Full=Nicotinic acid receptor;
DE   AltName: Full=Protein PUMA-G;
GN   Name=Hcar2; Synonyms=Gpr109, Gpr109a, Gpr109b, Niacr1, Pumag;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12646212; DOI=10.1016/s0006-291x(03)00342-5;
RA   Soga T., Kamohara M., Takasaki J., Matsumoto S., Saito T., Ohishi T.,
RA   Hiyama H., Matsuo A., Matsushime H., Furuichi K.;
RT   "Molecular identification of nicotinic acid receptor.";
RL   Biochem. Biophys. Res. Commun. 303:364-369(2003).
RN   [2]
RP   FUNCTION, TISSUE SPECIFICITY, AND CHARACTERIZATION.
RX   PubMed=12522134; DOI=10.1074/jbc.m210695200;
RA   Wise A., Foord S.M., Fraser N.J., Barnes A.A., Elshourbagy N., Eilert M.,
RA   Ignar D.M., Murdock P.R., Steplewski K., Green A., Brown A.J., Dowell S.J.,
RA   Szekeres P.G., Hassall D.G., Marshall F.H., Wilson S., Pike N.B.;
RT   "Molecular identification of high and low affinity receptors for nicotinic
RT   acid.";
RL   J. Biol. Chem. 278:9869-9874(2003).
RN   [3]
RP   FUNCTION.
RX   PubMed=19141678; DOI=10.1152/ajpendo.91004.2008;
RA   Plaisance E.P., Lukasova M., Offermanns S., Zhang Y., Cao G., Judd R.L.;
RT   "Niacin stimulates adiponectin secretion through the GPR109A receptor.";
RL   Am. J. Physiol. 296:E549-E558(2009).
CC   -!- FUNCTION: Acts as a high affinity receptor for both nicotinic acid
CC       (also known as niacin) and (D)-beta-hydroxybutyrate and mediates
CC       increased adiponectin secretion and decreased lipolysis through G(i)-
CC       protein-mediated inhibition of adenylyl cyclase. This pharmacological
CC       effect requires nicotinic acid doses that are much higher than those
CC       provided by a normal diet. Mediates nicotinic acid-induced apoptosis in
CC       mature neutrophils. Receptor activation by nicotinic acid results in
CC       reduced cAMP levels which may affect activity of cAMP-dependent protein
CC       kinase A and phosphorylation of target proteins, leading to neutrophil
CC       apoptosis. The rank order of potency for the displacement of nicotinic
CC       acid binding is 5-methyl pyrazole-3-carboxylic acid = pyridine-3-acetic
CC       acid > acifran > 5-methyl nicotinic acid = acipimox >> nicotinuric acid
CC       = nicotinamide. {ECO:0000269|PubMed:12522134,
CC       ECO:0000269|PubMed:12646212, ECO:0000269|PubMed:19141678}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in adipose tissue, lung and spleen.
CC       {ECO:0000269|PubMed:12522134, ECO:0000269|PubMed:12646212}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB103062; BAC58009.1; -; mRNA.
DR   RefSeq; NP_852141.1; NM_181476.1.
DR   AlphaFoldDB; Q80Z39; -.
DR   SMR; Q80Z39; -.
DR   STRING; 10116.ENSRNOP00000036057; -.
DR   BindingDB; Q80Z39; -.
DR   ChEMBL; CHEMBL4731; -.
DR   DrugCentral; Q80Z39; -.
DR   GuidetoPHARMACOLOGY; 312; -.
DR   iPTMnet; Q80Z39; -.
DR   PhosphoSitePlus; Q80Z39; -.
DR   PaxDb; 10116-ENSRNOP00000036057; -.
DR   Ensembl; ENSRNOT00000032249.2; ENSRNOP00000036057.1; ENSRNOG00000026653.2.
DR   Ensembl; ENSRNOT00055027138; ENSRNOP00055021878; ENSRNOG00055015968.
DR   Ensembl; ENSRNOT00060005240; ENSRNOP00060003876; ENSRNOG00060003186.
DR   Ensembl; ENSRNOT00065012542; ENSRNOP00065009239; ENSRNOG00065007951.
DR   GeneID; 353250; -.
DR   KEGG; rno:353250; -.
DR   UCSC; RGD:727952; rat.
DR   AGR; RGD:727952; -.
DR   CTD; 338442; -.
DR   RGD; 727952; Hcar2.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00990000203619; -.
DR   HOGENOM; CLU_009579_8_2_1; -.
DR   InParanoid; Q80Z39; -.
DR   OMA; KWDWKFG; -.
DR   OrthoDB; 5354998at2759; -.
DR   PhylomeDB; Q80Z39; -.
DR   TreeFam; TF330775; -.
DR   Reactome; R-RNO-3296197; Hydroxycarboxylic acid-binding receptors.
DR   Reactome; R-RNO-373076; Class A/1 (Rhodopsin-like receptors).
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   PRO; PR:Q80Z39; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000026653; Expressed in spleen and 12 other cell types or tissues.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IEA:Ensembl.
DR   GO; GO:0070553; F:nicotinic acid receptor activity; IDA:UniProtKB.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; IDA:UniProtKB.
DR   GO; GO:0001781; P:neutrophil apoptotic process; ISO:RGD.
DR   GO; GO:0070165; P:positive regulation of adiponectin secretion; IDA:UniProtKB.
DR   GO; GO:0033031; P:positive regulation of neutrophil apoptotic process; ISS:UniProtKB.
DR   CDD; cd15201; 7tmA_HCAR1-3; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR051893; HCARs.
DR   PANTHER; PTHR46048; HYDROXYCARBOXYLIC ACID RECEPTOR 2; 1.
DR   PANTHER; PTHR46048:SF6; HYDROXYCARBOXYLIC ACID RECEPTOR 2; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Cell membrane; Disulfide bond; G-protein coupled receptor;
KW   Membrane; Phosphoprotein; Receptor; Reference proteome; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..360
FT                   /note="Hydroxycarboxylic acid receptor 2"
FT                   /id="PRO_0000069606"
FT   TOPO_DOM        1..30
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        31..51
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        52..60
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        61..81
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        82..98
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        99..119
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        120..140
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        141..161
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        162..189
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        190..210
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        211..226
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        227..247
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        248..270
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        271..291
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        292..360
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          320..360
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         325
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EP66"
FT   DISULFID        97..174
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
SQ   SEQUENCE   360 AA;  41459 MW;  975BDEBCA448A6C5 CRC64;
     MSKQNHFLVI NGKNCCVFRD ENIAKVLPPV LGLEFVFGLL GNGLALWIFC FHLKSWKSSR
     IFLFNLAVAD FLLIICLPFL TDNYVQNWDW RFGSIPCRVM LFMLAMNRQG SIIFLTVVAV
     DRYFRVVHPH HFLNKISNRT AAIISCFLWG ITIGLTVHLL YTDMMTRNGD ANLCSSFSIC
     YTFRWHDAMF LLEFFLPLGI ILFCSGRIIW SLRQRQMDRH VKIKRAINFI MVVAIVFVIC
     FLPSVAVRIR IFWLLYKHNV RNCDIYSSVD LAFFTTLSFT YMNSMLDPVV YYFSSPSFPN
     FFSTCINRCL RRKTLGEPDN NRSTSVELTG DPSTIRSIPG ALMTDPSEPG SPPYLASTSR
//
